Abstract
Neuromuscular disorders constitute a heterogeneous group of chronic, genetic or immunological disorders that affect all age groups. Many of the affected patients have muscle weakness, respiratory and cardiovascular disorders, and some of them require the use of immunosuppressive drugs or infusion therapies in the hospital setting.
Currently, the world is facing the pandemic caused by Coronavirus Disease 2019, (Coronavirus Disease 2019, COVID-19), which is the entity caused by infection by the severe respiratory acute syndrome 2, SARS-CoV-2). In this pathology, factors of poor prognosis have been described, among which are age over 60 years, comorbidities such as diabetes mellitus, lung disease, cardiovascular disease, high blood pressure, cancer and immunosuppression.
Taking into account the aforementioned, the need arises to establish general recommendations for the care of patients with neuromuscular pathologies during the pandemic, based on the available literature that allows initial orientation in the management of patients.
References
Saavedra, C. Grupo ACIN- IETS de Consenso Colombiano para recomendaciones de atención COVID19. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/ Covid-19 en establecimientos de atención de la salud Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3):1- 153.
Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, Howard J, et al. International MG/COVID-19 Working Group, Guidance for the management of myasthenia gravis (MG) and Lambert - Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci 2020;412:116803. https://doi.org/10.1016/j.jns.2020.116803
Gulati A, Pomeranz C, Qamar Z, Thomas S, Frisch D, George G, et al. A comprehensive review of manifestations of novel coronaviruses in the context of deadly COVID-19 global pandemic. Am J Med Sci. 2020 [Consultado 31 Mayo 2020]. doi: doi: https://doi.org/10.1016/j.amjms.2020.05.006
.
Kumar M, Taki K, Gahlot R, Sharma A, Dhangar K. A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment. Sci Total Environ 2020;734:1-13. ISSN: 1879-1026.
Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020;201(11):1372-1379. doi:10.1164/rccm.202003-0543OC-
Solé G, Sarlort-Campana E, Pereon Y, Stojkovic T, Wahbi K, Cintas P, et al. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Revue neurologique. 2020;176(6):507-515. https://doi.org/10.1016/j.neurol.2020.04.0042.
Public Health, England. Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. [Internet]. [Consultado 31 May 2020]. Disponible en: Disponible en: https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19
.
Torres S, Lizarazo J, Picón A, Rodríguez G y Carreño L. Orientaciones de medidas preventivas y de mitigación para contener la infección respiratoria aguda por COVID-19, dirigidas a la población en general. Ministerio de salud y protección social Bogotá, marzo de 2020. Gestión de las intervenciones individuales y colectivas para la promoción de la salud y prevención de la enfermedad. [Internet]. [Consultado 31 May 2020]. Disponible en: Disponible en: https://www.acin.org/images/guias/coronavirus/ORIENT_ENTORNO_HOGAR_Y_PROP_HORIZ.pdf
.
Wechsler LR. Advantages and limitations of teleneurology. JAMA Neurol 2015;72:349-54. http://dx.doi.org/10.1001/jamaneurol.2014.3844.
Gallegos S, Reyes L. Telesalud y telemedicina para la prestación de servicios de salud en la pandemia por Covid-19 GESTION DE PRESTACIÓN DE SERVICIOS EN SALUD. Ministerio de Salud y Protección Social Bogotá, abril de 2020. [Internet]. [Consultado 31 May 2020]. Disponible en: Disponible en: https://wwwminsalud.govco/Ministerio/Institucional/Procesos%20y%20procedimientos/PSSS04.pdf
Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose escalation study Lancet 2016;388:3017-3026. http://dx.doi.org/10.1016/S0140-6736(16)31408-8.
Hundsberger T, Rósler KM, Findling O. Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis. J Neurol. 2014;261:1684-90. http://dx.doi.org/10.1007/s00415-014-7402-z.
Scheidegger O, Leupold D, Sauter R, Findling O, Rósler KM, Hundsberger T. 36-months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry. J Neurol 2018; 265:2783-8. http://dx.doi.org/10.1007/s00415-018-9065-7.
Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang C-C, Ueda M, Kristen AV, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 2018;379:11-21. http://dx.doi.org/10.1056/NEJMoa1716153.
Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;105949. http://dx.doi.org/10.1016/j.ijantimicag.2020.105949.
Darmon M, Bouadma L, Morawiec E, Maury E, Constantin JM, Montravers P, et al. Recommandations d'experts portant sur la prise en charge en réanimation des patients en période d'épidémie a SARS-CoV2. 2020. Recommandations-dexperts-COVID-9-mars-2020.pdf. [Internet]. [Consultado 31 May 2020]. Disponible en: Disponible en: https://www.srlf.org/wp-content/uploads/2020/03/
Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur RespirJ 2019;53(4):1802339. http://dx.doi.org/10.1183/13993003.02339-2018.
San-Juan D, Ramos Jiménez C, Ximénez Camilli C, De La Cruz Reyes A, Aguirre Galindo G, Ramos Burbano E, et al. Guidance for clinical neurophysiology examination throughout the COVID-19 pandemic. Latin American chapter of the IFCN task force - COVID-19. Clin Neurophysiol. 2020;131(7):1589-1598. doi:10.1016/j.clinph.2020.04.011.
Kassardjian CD, Desai U, Narayanaswami P; AANEM Quality and Patient Safety Committee of the AANEM. Practical Guidance for Managing EMG Requests and Testing during the COVID-19 Pandemic. Muscle Nerve [Internet]. 2020 [Consultado 31 May 2020]; doi: 10.1002/mus.26891. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32277763/
.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.